Exclusive: European VC Forbion hires Dyne CEO, expands into US

Off Biotech, biotechnology, Business, cancer, drug development, drug prices, drug pricing, FDA, finance, Health, Human Health, Life Sciences, Medicare, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Read on today for some exclusive hiring news and a retraction of a high-profile paper on cancer detection.

Read the rest…

Read Original Article: Exclusive: European VC Forbion hires Dyne CEO, expands into US »

About The Author